Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Similar articles for PubMed (Select 10155251)

1.

Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases.

Morishita R, Gibbons GH, Dzau VJ.

J Interv Cardiol. 1995 Aug;8(4):377-81. Review. No abstract available.

PMID:
10155251
2.

Intravitreous anti-raf-1 kinase antisense oligonucleotide as an angioinhibitory agent in porcine preretinal neovascularization.

Danis R, Criswell M, Orge F, Wancewicz E, Stecker K, Henry S, Monia B.

Curr Eye Res. 2003 Jan;26(1):45-54.

PMID:
12789536
3.

[Antisense oligonucleotides: a new class of biologically active molecules].

Uteshev DB, Korostelev SA, Sergeev AV, Uteshev BS.

Eksp Klin Farmakol. 2004 May-Jun;67(3):76-9. Review. Russian.

PMID:
15341077
4.

Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.

Arora V, Devi GR, Iversen PL.

Curr Pharm Biotechnol. 2004 Oct;5(5):431-9.

PMID:
15544491
5.

Antisense oligonucleotides in cutaneous therapy.

Wraight CJ, White PJ.

Pharmacol Ther. 2001 Apr;90(1):89-104. Review.

PMID:
11448727
6.

[Antisense hypoxia inducible factor-1alpha and B7-1 combination gene therapy for mouse lymphoma].

Sun XY, Meng FQ, Jiang HC, Qiao HQ, Li W.

Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):404-7. Chinese.

PMID:
16188124
7.

Antisense oligonucleotides strategy in the treatment of hypertension.

Kagiyama S, Kagiyama T, Phillips MI.

Curr Opin Mol Ther. 2001 Jun;3(3):258-64. Review.

PMID:
11497350
8.

Antisense oligonucleotide treatments for psoriasis.

White PJ, Atley LM, Wraight CJ.

Expert Opin Biol Ther. 2004 Jan;4(1):75-81. Review.

PMID:
14680470
9.

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases.

Danis RP, Henry SP, Ciulla TA.

Expert Opin Pharmacother. 2001 Feb;2(2):277-91. Review.

PMID:
11336586
10.

[Molecular therapy for vascular disease using an oligonucleotide-based strategy].

Miyake T, Morishita R.

Nihon Yakurigaku Zasshi. 2007 Mar;129(3):158-62. Review. Japanese. No abstract available.

PMID:
17379964
11.

Setting sights on the treatment of ocular angiogenesis using antisense oligonucleotides.

Henry SP, Marcusson EG, Vincent TM, Dean NM.

Trends Pharmacol Sci. 2004 Oct;25(10):523-7. Review.

PMID:
15380936
12.

Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system.

Ogata N, Otsuji T, Matsushima M, Kimoto T, Yamanaka R, Takahashi K, Wada M, Uyama M, Kaneda Y.

Curr Eye Res. 1999 Apr;18(4):261-9.

PMID:
10372985
13.

An antisense oligonucleotide primer.

Hogrefe RI.

Antisense Nucleic Acid Drug Dev. 1999 Aug;9(4):351-7. Review. No abstract available.

PMID:
10463079
14.

Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics.

Dzau VJ, Mann MJ, Ehsan A, Griese DP.

J Thorac Cardiovasc Surg. 2001 Feb;121(2):206-16. No abstract available.

PMID:
11174725
15.

Making sense of antisense.

Murakami A.

Trends Mol Med. 2001 Oct;7(10):430-1. No abstract available.

PMID:
11597507
16.

Cellular delivery of antisense oligonucleotides.

Lebedeva I, Benimetskaya L, Stein CA, Vilenchik M.

Eur J Pharm Biopharm. 2000 Jul;50(1):101-19. Review.

PMID:
10840195
17.

Antisense oligonucleotides: an evolving technology for the modulation of gene expression in human disease.

Green DW, Roh H, Pippin J, Drebin JA.

J Am Coll Surg. 2000 Jul;191(1):93-105. Review. No abstract available.

PMID:
10898188
18.

An antisense oligonucleotide targeting the growth hormone receptor inhibits neovascularization in a mouse model of retinopathy.

Wilkinson-Berka JL, Lofthouse S, Jaworski K, Ninkovic S, Tachas G, Wraight CJ.

Mol Vis. 2007 Aug 29;13:1529-38.

19.

The future of antisense oligonucleotides in the treatment of respiratory diseases.

Ulanova M, Schreiber AD, Befus AD.

BioDrugs. 2006;20(1):1-11. Review.

PMID:
16573347
20.

Antisense therapeutics.

Persidis A.

Nat Biotechnol. 1999 Apr;17(4):403-4. No abstract available.

PMID:
10207893
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk